Assessing and comparing patient engagement in clinical cancer research: A cross-regional analysis between Europe and Japan using a structured evaluation tool
By enabling structured assessment and monitoring of PE, this tool supports the implementation of engagement policies across regions. Its adaptability may foster shared learning and cross-border collaboration, especially in regions where engagement frameworks are still emerging.
Authors
- Bertrand Tombal (ORCID: https://orcid.org/0000-0002-0093-8408)
- Keiko Katsui
- Ingrid Klingmann (ORCID: https://orcid.org/0000-0002-0733-0454)
- L Dewulf
- Laureline Gatellier (ORCID: https://orcid.org/0000-0002-0331-3235)
- Nicholas Brooke (ORCID: https://orcid.org/0000-0002-0181-8424)
- Kazuyuki Suzuki (ORCID: https://orcid.org/0000-0002-8179-6607)
- Yoshiyuki Majima
- Hadrien Charvat (ORCID: https://orcid.org/0000-0003-3624-1394)
- I. Shakhnenko
- Béatrice Serckx
- Kenichi Nakamura (ORCID: https://orcid.org/0000-0003-3534-8296)
- Tomohiro Matsuda
- Jin Higashijima
- Beata Juzyna
Institutions
- Cliniques Universitaires Saint-Luc (BE)
- Chiba University (JP)
- St. Marianna University School of Medicine (JP)
- Japan Agency for Medical Research and Development (JP)
- Pancreatic Cancer Action Network (US)
- Juntendo University (JP)
- National Cancer Centre Japan (JP)
- Service Public Federal Finances (BE)
- Novartis (Japan) (JP)
- European Organisation for Research and Treatment of Cancer (BE)
- UniCancer Group (FR)
- European Forum for Good Clinical Practice (BE)
Publication Details
- Journal
- Journal of Cancer Policy
- Published
- 2025-08-22
- DOI
- https://doi.org/10.1016/j.jcpo.2025.100634
- Primary Topic
- Mental Health and Patient Involvement
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Society for the Promotion of Science